Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 3, 1996, Pages 353-362

  Aaker, Aaron ^a   McCormack, James G ^b,c   Hirai, Tadakazu ^a   Musch, Timothy I ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Fatigue; Glucose; Lactic acid; Liver glycogen; Metabolism; Performance; Pyruvate dehydrogenase; Ranolazine; Skeletal muscle glycogen

Indexed keywords

GLUCOSE; LACTIC ACID; RANOLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENDURANCE; EXERCISE TEST; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; LACTATE BLOOD LEVEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TREADMILL EXERCISE;

ANIMALS; BLOOD GLUCOSE; CARDIAC OUTPUT, LOW; ENZYME INHIBITORS; EXERTION; FEMALE; GLYCOGEN; LACTIC ACID; MUSCLE, SKELETAL; MYOCARDIAL INFARCTION; PIPERAZINES; RATS; RATS, WISTAR;

EID: 0029796954     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199609000-00002     Document Type: Article

References (46)

1. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic heart failure. Circulation 1982;65:1213-23.
2. Wilson JR, Fink L, Maris J, et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorous-31 nuclear magnetic resonance. Circulation 1985;71:57-62.
3. Wiener DH, Fink LI, Maris J, Jones RA. Chance B, Wilson JR. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986;73:1127-36.
4. Massie B, Conway M, Yonge R, et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987;76:1364-73.
5. Poole-Wilson PA, Buller NP, Lipkin DP. Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure. Am J Cardiol 1988;62:49E-52E.
6. Zelis R, Sinoway L, Musch T, Davis D. Vasoconstrictor mechanisms in congestive heart failure. Mod Concepts Cardiovasc Dis 1989;58:7-12.
7. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990;81:518-27.
8. Drexler H, Riede U, Munzel T, Honig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-9.
9. 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989;80:1338-46.
10. 2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res 1993;73:405-12.
11. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure: relation to skeletal muscle aerobic enzyme activity. Circulation 1991;84:1597-607.
12. Whitehouse S, Randle PJ. Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate. Biochem J 1973;134:651-3.
13. Evans OB, Stacpoole PW. Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate. Biochem Pharmacol 1982;31:1295-300.
14. Schnieder SH, Komanicky PM, Goodman MN, Ruderman NB. Dichloroacetate: effects on exercise endurance in untrained rats. Metabolism 1981;30:590-5.
15. Ludvik B, Mayer G, Stifter S, Putz D, Barnas U, Graf H. Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch 1993;423:251-4.
16. Wilson JR, Mancini DM, Ferraro N, Egler J. Effect of dichloroacetate on the exercise performance of patients with heart failure. J Am Coll Cardiol 1988;12:1464-9.
17. Crabb DW, Yount EA, Harris RA. The metabolic effects of dichloroacetate. Metabolism 1981;30:1024-39.
18. Katz R, Tai CN, Diener RM, McConnell RF, Semonick E. Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs. Toxicol Appl Pharmacol 1981;57:273-87.
19. Stacpoole PW, Harwood HJ, Cameron DF, et al. Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency. Fund Appl Toxicol 1990;14:327-37.
20. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 1996; 93:135-42.
21. Clarke B, Spedding M, Patmore L, McCormack JG. Protective effects of ranolazine in guinea pig hears and their association with increases in active pyruvate dehydrogenase. Br J Pharmacol 1993;109:748-50.
22. Clarke B, Wyatt KM, McCormack JG. Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism. J Mol Cell Cardiol (in press).
23. Jain D, Dasgupta P, Hughes LO, Lahiri A, Raftery EB. Ranolazine (RS-43285): a preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium. Eur J Clin Pharmacol 1990;38:111-4.
24. Cocco G, Rousseau MF, Bouvy T, et al. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with β-blocker or diltiazem. J Cardiovasc Pharmacol 1992;20:131-8.
25. Thadini U, Ezekowitz M, Fenney L, Chiang Y. Double blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Circulation 1994;90:726-34.
26. Conlee RK, Rennie MJ, Winder WW. Skeletal muscle glycogen content: diurnal variation and effects of fasting. Am J Physiol 1976;231:614-8.
27. Clark JH, Conlee RK. Muscle and liver glycogen content: diurnal variation and endurance. J Appl Physiol 1979;47: 425-8.
28. Gaesser GA, Brooks GA. Glycogen repletion following continuous and intermittent exercise to exhaustion. J Appl Physiol 1980;49:722-8.
29. Dohm GL, Tapscott EB, Barakat HA, Kasperek GJ. Influence of fasting on glycogen depletion in rats during exercise. J Appl Physiol 1983;55:830-3.
30. Sembrowich WL, Knutson MB, Gollnick PD. Muscle metabolism and cardiac function of the myopathic hamster following training. J Appl Physiol 1977;43:936-41.
31. Lowry OH, Passonneau JV. A flexible system of enzymatic analysis. New York: Academic Press, 1971.
32. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarction size and ventricular function in rats. Circ Res 1979; 44:503-12.
33. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function. Circ Res 1981;49:618-26.
34. Zimmer HG, Gerdes AM, Lortet S, Mall G. Changes in heart function and cardiac cell size in rats with chronic myocardial infarction. J Mol Cell Cardiol 1990;22:1231-43.
35. Musch TI, Moore RL, Riedy M, et al. Glycogen concentrations and endurance capacity of rats with chronic heart failure. J Appl Physiol 1988;64:1153-9.
36. Musch TI, Ghaul MR, Tranchitella V, Zelis R. Skeletal muscle glycogen depletion during submaximal exercise in rats with chronic heart failure. Basic Res Cardiol 1990;85:606-18.
37. Musch TI, Terrell JA. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise. Am J Physiol (Heart Circ Physiol) 1992;262: H411-9.
38. Louridas G, Kakoura M, Patakas D, Angomachalelis N. Pulmonary hypertension and respiratory failure in the development of right ventricular hypertrophy in patients with chronic obstructive pulmonary disease. Respiration 1984;46: 52-60.
39. McCormack JG, Baracos VE, Barr R, Lopaschuk GD. Effects of ranolazine on oxidative substrate preference in epitrochlearis muscle. J Appl Physiol 1996 (in press).
40. Lacey JH, Randle PJ. Inhibition of lactate gluconeogenesis in rat kidney by dichloroacetate. Biochem J 1978;170:551-60.
41. Hultman E, Del Canale S, Sjoholm H. Effect of induced metabolic acidosis on intracellular pH, buffer capacity and contraction force of human skeletal muscle. Clin Sci 1985; 69:505-10.
42. Metzger JM, Fitts RH. Role of intracellular pH in muscle fatigue. J Appl Physiol 1987;62:1392-7.
43. 31P Nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue. J Clin Invest 1988;81:1190-6.
44. Weiner MW, Moussavi RS, Baker AJ, Boska MD, Miller RG. Constant relationships between force, phosphate concentration, and pH in muscles with differential fatigability. Neurology 1990;40:1888-93.
45. Brooks GA, Gaesser GA. End points of lactate and glucose metabolism after exhausting exercise. J Appl Physiol 1980; 49:1057-69.
46. Conlee RK. Muscle glycogen and exercise endurance: a twenty-year perspective. In: Pnadolf KB, ed. Exercise and sports science reviews. New York: MacMillan, 1987:1-28.